Exponent (NASDAQ:EXPO) Price Target Raised to $100.00

Exponent (NASDAQ:EXPO) had its target price lifted by JPMorgan Chase & Co. from $90.00 to $100.00 in a report issued on Friday morning,Benzinga reports. The brokerage currently has an overweight rating on the business services provider’s stock.

EXPO has been the subject of several other reports. Weiss Ratings raised shares of Exponent from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, October 9th. UBS Group set a $72.00 price target on shares of Exponent and gave the company a “neutral” rating in a research report on Friday, July 31st. Two analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $86.00.

Exponent Stock Performance

Shares of EXPO opened at $80.26 on Friday. Exponent has a 12 month low of $51.91 and a 12 month high of $83.18. The company has a market cap of $3.82 billion, a price-to-earnings ratio of 34.59 and a beta of 0.66. The business’s fifty day simple moving average is $70.19 and its two-hundred day simple moving average is $66.64.

Exponent (NASDAQ:EXPO) last posted its quarterly earnings results on Thursday, October 29th. The business services provider reported $0.64 EPS for the quarter, beating the consensus estimate of $0.60 by $0.04. Exponent had a net margin of 17.40% and a return on equity of 34.61%. The business had revenue of $173.73 million during the quarter, compared to analyst estimates of $149.64 million. During the same quarter in the previous year, the business posted $0.55 EPS. The company’s quarterly revenue was up 11.7% compared to the same quarter last year. As a group, research analysts forecast that Exponent will post 2.33 EPS for the current year.

Exponent Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, December 18th. Investors of record on Friday, December 4th will be given a $0.31 dividend. This represents a $1.24 annualized dividend and a dividend yield of 1.5%. The ex-dividend date of this dividend is Friday, December 4th. Exponent’s dividend payout ratio (DPR) is 53.45%.

Insiders Place Their Bets

In other Exponent news, CEO Catherine Corrigan sold 1,707 shares of Exponent stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $66.28, for a total transaction of $113,139.96. Following the transaction, the chief executive officer owned 129,108 shares of the company’s stock, valued at $8,557,278.24. The trade was a 1.30% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.70% of the stock is owned by insiders.

Institutional Investors Weigh In On Exponent

Hedge funds and other institutional investors have recently made changes to their positions in the business. Chicago Partners Investment Group LLC bought a new stake in shares of Exponent in the third quarter valued at $226,000. Covestor Ltd increased its holdings in Exponent by 10.3% during the 3rd quarter. Covestor Ltd now owns 2,050 shares of the business services provider’s stock worth $134,000 after purchasing an additional 192 shares during the period. Bridge City Capital LLC increased its holdings in shares of Exponent by 21.6% during the third quarter. Bridge City Capital LLC now owns 49,231 shares of the business services provider’s stock valued at $3,221,000 after acquiring an additional 8,729 shares in the last quarter. Vise Technologies Inc. acquired a new position in Exponent in the 3rd quarter worth about $343,000. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new position in Exponent during the third quarter worth about $216,000. 92.37% of the stock is currently owned by institutional investors and hedge funds.

Key Exponent News

Here are the key news stories impacting Exponent this week:

• Positive Sentiment: Quarterly earnings and revenue topped estimates. Exponent reported third-quarter EPS of $0.64, above the $0.60 consensus estimate and up from $0.55 a year earlier. Revenue reached $173.7 million versus an expected $149.6 million, while year-over-year revenue increased 11.7%. Exponent Tops Q3 Earnings and Revenue Estimates
• Positive Sentiment: Profitability and cash generation remained solid. Reported net income was approximately $30.9 million, operating profit increased sharply, and operating cash flow was $30.9 million. The results indicate improving operating leverage as revenue expands. Exponent Releases Q3 2026 Earnings
• Positive Sentiment: Management raised its 2026 outlook. The improved guidance reinforces investor expectations for continued growth and supports the positive reaction to the earnings release. Exponent Posts Strong Q3 Results
• Positive Sentiment: The company declared a regular quarterly dividend of $0.31 per share. The dividend is payable December 18 to shareholders of record December 4, representing an annualized payout of $1.24 and a yield of roughly 1.5%. Exponent Declares Quarterly Dividend
• Neutral Sentiment: Exponent plans to acquire Crane Building Services & Utilities in a carve-out transaction. The deal could broaden its service offering, although financial terms and expected earnings benefits were not provided. Exponent to Acquire Crane Building Services and Utilities
• Negative Sentiment: Recent insider trading has been weighted toward selling, with 10 reported sales and only one purchase over the past six months. This may create a modest sentiment headwind, though it is less significant than the earnings beat.

About Exponent

Exponent, Inc is a science and engineering consulting company that helps clients investigate complex technical issues, manage risks, and develop solutions. Its consultants work across disciplines including engineering, materials science, biomechanics, human factors, environmental science, health, data sciences, and economics.

The company provides failure analysis, product safety and testing, accident reconstruction, environmental and health assessments, regulatory support, and expert testimony.